Hughes Owen
- SEC CIK
- 0001575933
In the past year, 1 open-market purchase filing worth $2.50M and no sales.
Current role at each company
- XOMA XOMA Royalty CorpChief Executive Officeras of Jul 14, 2026
- CCCC C4 Therapeutics, Inc.Directoras of Jun 26, 2026
- ANAB Anaptysbio, IncDirectoras of May 13, 2026
- IMA ImageneBio, Inc.Directoras of Jun 10, 2024
- Radius Health, Inc.Directoras of Aug 15, 2022
Show 2 more companies
- PRDS Pardes Biosciences, Inc.Directoras of Dec 30, 2021
- Translate Bio, Inc.Directoras of Sep 14, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $2.50M
- 1 filing
- Sold
- –
- 0 filings
- Net
- +$2.50M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Hughes Owen as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
XOMA XOMA Royalty Corp
Chief Executive Officer6 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 8, 2025 (view filing) | Dec 4 | 4 days | Hughes OwenChief Executive Officer | PPurchaseDepositary Shares - 8.375% B Cumulative Stock | +100.0K | $25.05 | +$2.50M | +5,000.0%102.0K after | |
| May 21, 2025 (view filing) | May 20 | 1 day | Hughes OwenChief Executive Officer | SSale | −25.6K | $25.38 | −$650.7K | −29.0%62.7K after | |
| Nov 13, 2024 (view filing) | Nov 13 | Same day | Hughes OwenChief Executive Officer | SSale | −21.9K | $29.95 | −$655.3K | −38.5%35.0K after | |
| Oct 4, 2023 (view filing) | Oct 2 | 2 days | Hughes OwenExec Chairman and Interim CEO | PPurchase | +1.00K | $13.83 | +$13.8K | +40.0%3.50K after | |
| Sep 27, 2023 (view filing) | Sep 25-26 | 2 days | Hughes OwenExec Chairman and Interim CEO | PPurchase | +2.50K | $14.43 | +$36.1K | New position2.50K after | 2 lots |
| May 25, 2023 (view filing) | May 23-24 | 2 days | Hughes OwenInterim CEO | PPurchaseDepositary Shares - 8.375% B Cumulative Stock | +2.00K | $23.63 | +$47.3K | New position2.00K after | 3 lots |
Translate Bio, Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 14, 2021 (view filing) | Sep 14 | Same day | Hughes OwenDirector | SSale | −29.9K | $38.00 | −$1.13M | −100.0%0 after | |
| Sep 14, 2021 (view filing) | Sep 14 | Same day | Hughes OwenDirector | SSale | −95.9K | $0.00 | $0 | –0 after | Derivative4 lots |